000 01324 a2200385 4500
005 20250512200509.0
264 0 _c19841227
008 198412s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(84)91507-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHayes, P C
245 0 0 _aInfluence of propranolol on weight and salt and water homoeostasis in chronic liver disease.
_h[electronic resource]
260 _bLancet (London, England)
_cNov 1984
300 _a1064-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdipose Tissue
_xdrug effects
650 0 4 _aBody Weight
650 0 4 _aChronic Disease
650 0 4 _aClinical Trials as Topic
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLiver Diseases
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPropranolol
_xpharmacology
650 0 4 _aSkinfold Thickness
650 0 4 _aSodium
_xurine
650 0 4 _aTime Factors
650 0 4 _aWater-Electrolyte Balance
_xdrug effects
700 1 _aStewart, W W
700 1 _aBouchier, I A
773 0 _tLancet (London, England)
_gvol. 2
_gno. 8411
_gp. 1064-8
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(84)91507-1
_zAvailable from publisher's website
999 _c6150213
_d6150213